Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

>> Preview...
In the News
Greg Scott presents industry update during JPMorgan
>> View video…

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

Lee’s Pharma Acquires Oral Antibacterial Drug from Nippon Shinyaku

publication date: Mar 4, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Lee’s Pharmaceutical Holdings of Hong Kong has in-licensed the exclusive China rights to the oral antibacterial drug Prulifloxacin from Nippon Shinyaku Co., Ltd. of Japan. Lee’s will make an upfront payment, milestone payments based on sales levels, and it will pay royalties, though specific amounts were not disclosed. More details...

Stock Symbol: (HKGEM: 8221)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events
April 14, 2010
Guangzhou, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
Suzhou, China
June 23-24, 2010
 
Partner Events

China 2010 Pharmaceutical R&D Summit
Shanghai, China
April 5-8, 2010
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners